{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:45:15Z","timestamp":1770410715364,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11892-008-0004-3","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T09:35:44Z","timestamp":1201858544000},"page":"12-19","source":"Crossref","is-referenced-by-count":25,"title":["Endocannabinoid system overactivity and the metabolic syndrome: Prospects for treatment"],"prefix":"10.1007","volume":"8","author":[{"given":"Jennifer M.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen N.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,2]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I. Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P, et al.: Regulation, function and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006, 91:3171\u20133180.","journal-title":"J Clin Endocrinol Metab"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y. Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R: Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964, 86:1646\u20131647.","journal-title":"J Am Chem Soc"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"L.A. Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, et al.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561\u2013564.","journal-title":"Nature"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","volume":"68","author":"A.C. Howlett","year":"2002","unstructured":"Howlett AC: The cannabinoid receptors. Prostaglandins Other Lipid Mediat 2002, 68:619\u2013631.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","volume":"58","author":"A. Ameri","year":"1999","unstructured":"Ameri A: The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58:315\u2013318.","journal-title":"Prog Neurobiol"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"A.C. Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, et al.: International Union of Pharmacology. XXVII. Classification of cannabinoids receptors. Pharmacol Rev 2002, 54:161\u2013202.","journal-title":"Pharmacol Rev"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","volume":"279","author":"Y. Okamoto","year":"2004","unstructured":"Okamoto Y, Morishita J, Tsuboi K, et al.: Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 2004, 279:5298\u20135305.","journal-title":"J Biol Chem"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D. Piomelli","year":"2003","unstructured":"Piomelli D: The molecular logic of endocannabinoid signaling. Nat Rev Neurosci 2003, 4:873\u2013884.","journal-title":"Nat Rev Neurosci"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S. Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Feldpausch M, et al.: Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005, 54:2838\u20132843.","journal-title":"Diabetes"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"T.C. Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, et al.: Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002, 136:550\u2013557.","journal-title":"Br J Pharmacol"},{"key":"4_CR11","doi-asserted-by":"crossref","unstructured":"Sharkey KA, Pittman QJ: Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies. Sci STKE 2005, pe15.","DOI":"10.1126\/stke.2772005pe15"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","volume":"8","author":"V. Marzo Di","year":"2005","unstructured":"Di Marzo V, Matias I: Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005, 8:585\u2013589.","journal-title":"Nat Neurosci"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V. Marzo Di","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, et al.: Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822\u2013825.","journal-title":"Nature"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(03)03046-4","volume":"983","author":"L. Hanus","year":"2003","unstructured":"Hanus L, Avraham Y, Ben-Shushan D, et al.: Short term fasting and prolonged semistarvation have opposite effects on 2-AG levels in the mouse brain. Brain Res 2003, 983:144\u2013151.","journal-title":"Brain Res"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","volume":"392","author":"S. Hao","year":"2000","unstructured":"Hao S, Avaraham Y, Mechoulam R, et al.: Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 2000, 392:147\u2013156.","journal-title":"Eur J Pharmacol"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tem.2006.11.006","volume":"18","author":"I. Matias","year":"2006","unstructured":"Matias I, Di Marzo V: Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 2006, 18:27\u201337.","journal-title":"Trends Endocrinol Metab"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","volume":"28","author":"C. Ravinet Trillou","year":"2004","unstructured":"Ravinet Trillou C, Delgorge C, et al.: CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004, 28:640\u2013648.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","volume":"63","author":"M. Bensaid","year":"2003","unstructured":"Bensaid M, Gary-Bobo M, Esclangon A, et al.: The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003, 63:908\u2013914.","journal-title":"Mol Pharmacol"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","volume":"112","author":"D. Cota","year":"2003","unstructured":"Cota D, Marsiacano G, Tschop M, et al.: The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003, 112:423\u2013431.","journal-title":"J Clin Invest"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/mol.105.015040","volume":"69","author":"M. Gary-Bobo","year":"2006","unstructured":"Gary-Bobo M, Elachouri G, Scatton B, et al.: The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol Pharmacol 2006, 69:471\u2013478.","journal-title":"Mol Pharmacol"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","volume":"55","author":"M. Bluher","year":"2006","unstructured":"Bluher M, Engeli S, Kloting N, et al.: Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006, 55:3053\u20133060.","journal-title":"Diabetes"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diabetes.52.4.942","volume":"52","author":"S. Engeli","year":"2003","unstructured":"Engeli S, Fledpausch M, Gorzelniak K, et al.: Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003, 52:942\u2013947.","journal-title":"Diabetes"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.amjmed.2007.01.004","volume":"120","author":"S.C. Woods","year":"2007","unstructured":"Woods SC: Role for the endocannabinoid system in regulating cardiovascular and metabolic risk factors. Am J Med 2007, 120:S19\u2013S25.","journal-title":"Am J Med"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D. Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, DePetrillo M, Pacher P, et al.: Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005, 115:1298\u20131305.","journal-title":"J Clin Invest"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2337\/diacare.27.8.2057","volume":"27","author":"J. Medina","year":"2004","unstructured":"Medina J, Fern\u00e1ndez-Salazar L, Garc\u00eda-Buey L, Moreno-Otero R: Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004, 27:2057\u20132066.","journal-title":"Diabetes Care"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F. Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc F, Julien B, Grenard P, et al.: CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006, 12:671\u2013676.","journal-title":"Nat Med"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.ijo.0802847","volume":"29","author":"Y.L. Liu","year":"2005","unstructured":"Liu YL, Connoley IP, Wilson CA, Stock MJ: Effects of CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in lep(ob)\/lep(ob) mice. Int J Obes Relat Metab Disord 2005, 29:183\u2013187.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","volume":"27","author":"U. Pagotto","year":"2006","unstructured":"Pagotto U, Marsicano G, Cota D, et al.: The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006, 27:73\u2013100.","journal-title":"Endocr Rev"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","volume":"39","author":"P. Juan-Pico","year":"2005","unstructured":"Juan-Pico P, Fuentes E, Bermudez-Silva FJ, et al.: Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta cell. Cell Calcium 2005, 39:155\u2013162.","journal-title":"Cell Calcium"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.12.016","volume":"531","author":"F.J. Bermudez-Siva","year":"2006","unstructured":"Bermudez-Siva FJ, Serrano A, Diaz-Molina F, et al.: Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol 2006, 531:282\u2013284.","journal-title":"Eur J Pharmacol"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2007.02.066","volume":"565","author":"F.J. Bermudez-Silva","year":"2007","unstructured":"Bermudez-Silva FJ, Sanchez-Vera I, Suarez J, et al.: Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol 2007, 565:207\u2013211.","journal-title":"Eur J Pharmacol"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","volume":"22","author":"R. Gomez","year":"2002","unstructured":"Gomez R, Navarro M, Ferrer B, et al.: A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 2002, 22:9612\u20139617.","journal-title":"J Neurosci"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.coph.2004.05.007","volume":"4","author":"A.A. Coutts","year":"2004","unstructured":"Coutts AA, Izzo AA: The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol 2004, 4:572\u2013579.","journal-title":"Curr Opin Pharmacol"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"S.M. Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.: Diagnosis and management of the metabolic syndrome. An American Heart Association\/National Heat, Lung and Blood Institute Scientific Statement. Circulation 2005, 112:2735\u20132752.","journal-title":"Circulation"},{"key":"4_CR35","unstructured":"American Heart Association: Heart disease and stroke statistics-2007 Update-At-a-Glance. Available at http:\/\/www.americanheart.org\/downloadable\/heart\/1166711577754HS_StatsInsideText.pdf . Accessed October 25, 2007."},{"key":"4_CR36","unstructured":"National diabetes information clearinghouse: National diabetes statistics. Available at http:\/\/diabetes.niddk.nih.gov\/dmpubs\/statistics\/ . Accessed August 10, 2007."},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","volume":"27","author":"E.S. Ford","year":"2004","unstructured":"Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004, 27:2444\u20132449.","journal-title":"Diabetes Care"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(02)03245-6","volume":"952","author":"J.A. Harrold","year":"2002","unstructured":"Harrold JA, Elliott JC, King PJ, et al.: Down-regulation of cannabinoid-1 (CB1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 2002, 952:232\u2013238.","journal-title":"Brain Res"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/molehr\/gah130","volume":"11","author":"M. Maccarrone","year":"2005","unstructured":"Maccarrone M, Fride E, Bisogno T, et al.: Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob\/ob) mice and implications for fertility. Mol Hum Reprod 2005, 11:21\u201328.","journal-title":"Mol Hum Reprod"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","volume":"31","author":"M. Cote","year":"2007","unstructured":"Cote M, Matias I, Lemieux I, et al.: Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors. Int J Obes 2007, 31:692\u2013699.","journal-title":"Int J Obes"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M. Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, Heaulme M, et al.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994, 350:240\u2013244.","journal-title":"FEBS Lett"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00545.2002","volume":"284","author":"C. Ravinet-Trillou","year":"2003","unstructured":"Ravinet-Trillou C, Arnone M, Delgorge C, et al.: Antiobesity effect of SR141716, a CB1 receptor antagonist, in diet induced obese mice. Am J Physiol Regul Integr Comp Physiol 2003, 284:R345\u2013R353.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.04-3177fje","volume":"19","author":"O. Jbilo","year":"2005","unstructured":"Jbilo O, Ravinet-Trillou C, Arnone M, et al.: The CB1 receptor antagonist rimonabant reverses the diet induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005, 19:1567\u20131569.","journal-title":"FASEB J"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","volume":"353","author":"J.P. Despres","year":"2005","unstructured":"Despres JP, Golay A, Sjostrom L: Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005, 353:2121\u20132134.","journal-title":"N Engl J Med"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"F.X. Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al.: Effect of rimonabant, a cannabinoid receptor 1 blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006, 295:761\u2013765.","journal-title":"JAMA"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"L.F. Gaal Van","year":"2005","unstructured":"Van Gaal LF, Rissanen AM, Scheen AJ, et al.: Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005, 365:1389\u20131397.","journal-title":"Lancet"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","volume":"368","author":"A.J. Scheen","year":"2006","unstructured":"Scheen AJ, Finer N, Hollander P, et al.: Efficacy and tolerability of Rimonabant in overweight or obese patients with type 2 diabetes: a randomized controlled study. Lancet 2006, 368:1660\u20131672.","journal-title":"Lancet"},{"issue":"suppl4","key":"4_CR48","first-page":"230A","volume":"23","author":"A. Iranmanesh","year":"2006","unstructured":"Iranmanesh A, Rosenstock J, Hollander P: SERENADE: Rimonabant monotherapy for treatment of multiple cardiometabolic risk factors in treatment-naive patients with type 2 diabetes. Diabet Med 2006, 23(suppl 4):230A (637b).","journal-title":"Diabet Med"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-008-0004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-008-0004-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-008-0004-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:56:18Z","timestamp":1559418978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-008-0004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11892-008-0004-3","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}